Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors

Since patients with medullary thyroid cancer (MTC) often have metastatic disease at the time of diagnosis, the development of efficient systemic treatment options for MTC is important. Vandetanib and cabozantinib are two tyrosine kinase inhibitors (TKIs) that were recently approved by FDA and EMA fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandblom, Viktor, Spetz, Johan, Shubbar, Emman, Montelius, Mikael, Ståhl, Ingun, Swanpalmer, John, Nilsson, Ola, Forssell-Aronsson, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252631/
https://www.ncbi.nlm.nih.gov/pubmed/32459817
http://dx.doi.org/10.1371/journal.pone.0233720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252631/
https://www.ncbi.nlm.nih.gov/pubmed/32459817
http://dx.doi.org/10.1371/journal.pone.0233720

Ejemplares similares